$EXAS stock has now risen 2% today, according to our price data from Polygon. There has been approximately $438,159,125 of trading volume.
It has been the 184th most-searched ticker on Quiver Quantitative over the last day, out of 10,085 total tickers searched.
Here is what we see in our data on $EXAS (you can track the company live on Quiver's $EXAS stock page):
$EXAS Insider Trading Activity
$EXAS insiders have traded $EXAS stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $EXAS stock by insiders over the last 6 months:
- KATHERINE S ZANOTTI has made 0 purchases and 2 sales selling 15,207 shares for an estimated $950,612.
- JAMES EDWARD DOYLE has made 0 purchases and 2 sales selling 3,485 shares for an estimated $182,399.
- JAMES HERRIOTT (SVP, General Counsel & Sec) sold 1,500 shares for an estimated $90,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EXAS Hedge Fund Activity
We have seen 263 institutional investors add shares of $EXAS stock to their portfolio, and 283 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,700,607 shares (-42.2%) from their portfolio in Q2 2025, for an estimated $143,510,255
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,596,623 shares (-89.0%) from their portfolio in Q2 2025, for an estimated $137,984,546
- GOLDMAN SACHS GROUP INC added 1,486,137 shares (+204.1%) to their portfolio in Q2 2025, for an estimated $78,973,320
- HOLOCENE ADVISORS, LP added 1,404,086 shares (+189.5%) to their portfolio in Q2 2025, for an estimated $74,613,130
- BLACKROCK, INC. removed 1,388,121 shares (-11.6%) from their portfolio in Q2 2025, for an estimated $73,764,749
- STATE STREET CORP removed 1,234,872 shares (-18.7%) from their portfolio in Q2 2025, for an estimated $65,621,098
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,219,545 shares (-39.0%) from their portfolio in Q2 2025, for an estimated $64,806,621
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$EXAS Government Contracts
We have seen $592,152 of award payments to $EXAS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TESTING SERVICES FOR PATIENT CARE: $323,800
- ONCOTYPE CANCER TESTING - OY 5 POP: 16 MARCH 2025 TO 15 MARCH 2026: $124,588
- ONCOTYPE GENETIC TESTING SERVICES: $114,305
- GENETIC TESTING PREVENTIONGENETICS LLC:1126164 [25-010421]: $29,459
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$EXAS Analyst Ratings
Wall Street analysts have issued reports on $EXAS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 11/04/2025
- BTIG issued a "Buy" rating on 11/04/2025
- Piper Sandler issued a "Overweight" rating on 10/08/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
- Barclays issued a "Overweight" rating on 10/02/2025
- Craig-Hallum issued a "Buy" rating on 09/11/2025
To track analyst ratings and price targets for $EXAS, check out Quiver Quantitative's $EXAS forecast page.
$EXAS Price Targets
Multiple analysts have issued price targets for $EXAS recently. We have seen 11 analysts offer price targets for $EXAS in the last 6 months, with a median target of $75.0.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $77.0 on 11/04/2025
- Mark Massaro from BTIG set a target price of $85.0 on 11/04/2025
- Daniel Arias from Stifel set a target price of $80.0 on 11/04/2025
- Subbu Nambi from Guggenheim set a target price of $75.0 on 11/04/2025
- Catherine Schulte from Baird set a target price of $88.0 on 11/04/2025
- Bruce D. Jackson from Benchmark set a target price of $75.0 on 11/04/2025
- David Westenberg from Piper Sandler set a target price of $70.0 on 10/08/2025
You can track data on $EXAS on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
